Method for treating multiple sclerosis patients with anti-IL2R antibodies
Details for Australian Patent Application No. 2009285625 (hide)
International Classifications
Event Publications
3 February 2011 PCT application entered the National Phase
PCT publication WO2010/025321 Priority application(s): WO2010/025321
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009285628-Nanoparticles for immunotherapy
2009285624-Novel Hemipteran and coleopteran active toxin proteins from Bacillus thuringiensis
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser